Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2021-03-30 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
List Prezesa Zarządu Selvita SA do Akcjonariuszy_Podsumowanie Roku 2020
Audit Report / Information Classification · 95% confidence The document is a letter addressed to shareholders and partners, summarizing the company's (Selvita) performance, strategic achievements (acquisition of Fidelty, securing financing for a research center), and operational highlights for the year 2020. It discusses revenue growth, profitability (EBITDA, net profit), capital market performance (share price increase, inclusion in mWIG40 index), and winning the 'Stock Exchange Company of the Year' award. This content structure—a comprehensive review of the past fiscal year's operations, strategy, and financial results, often signed by the CEO/Chairman—is characteristic of an Annual Report or a section thereof, specifically the Management Discussion and Analysis (MDA) or Chairman's Letter. Since the text provides detailed operational and financial context for the entire year, it aligns best with the content expected in a comprehensive annual review, which is often filed as a 10-K in the US context, or a detailed Annual Report (AR) in other contexts. Given the detailed review of the full year's performance, it is classified as an Annual Report (10-K) or a comprehensive report (AR). Since it is a narrative summary rather than the formal 10-K filing itself, and given the context of a detailed yearly review, 'AR' (Audit Report / Information) is a possibility, but '10-K' (Annual Report) is the standard classification for comprehensive yearly performance reviews. However, the text reads like the introductory letter/MD&A section of a full annual report. If this were a standalone document, it would be an Annual Report (10-K). If it were just the audit opinion, it would be AR. Given the depth of operational review, 10-K is the most appropriate fit for a comprehensive annual review document. FY 2020
2021-03-30 Polish
GK Selvita_SSF_SSZ_XBRL_zip.xades
Audit Report / Information Classification · 95% confidence The provided document text consists entirely of XML digital signature blocks (specifically XAdES/XML-DSig structures) used to verify the integrity and authenticity of a file. The references within these signatures point to a ZIP file named "SELVITA-2020-12-31.zip". This strongly suggests the document itself is not the primary financial report but rather the metadata or container wrapper for a signed file, likely containing financial data for the period ending December 31, 2020. Since the content is purely technical signature data and does not contain narrative financial results, management discussion, or formal regulatory headers (like 10-K or ER), it does not fit the definitions for 10-K, ER, IR, or MDA. The presence of a signed file containing year-end data (2020-12-31) points towards an Annual Report (10-K) or an Audit Report (AR). However, because the document *is* the signature block and not the report itself, and given the lack of explicit regulatory form identification, the most appropriate classification based on the structure (a technical wrapper/attachment) and the fallback rule is Regulatory Filings (RNS), or potentially Financial Supplement Data (XLSX) if the ZIP contained raw data, but RNS is safer for generic signed attachments. Revisiting the definitions: The content is a digital signature wrapper for a file dated 2020-12-31. This date strongly implies year-end reporting. If this were the actual 10-K, the text would be extensive and contain the required sections. Since it's just signatures, it's an announcement or attachment wrapper. Given the specific date (year-end) and the fact that it's a signed attachment, it is most likely related to the Annual Report filing process, but the document *type* presented here is a technical signature block. Following Rule 2 (Menu vs Meal), if this were an announcement of the report, it would be RPA or RNS. Since it's the signature block *for* the data, and RNS is the general regulatory fallback for non-standard filings, RNS is the best fit for this technical wrapper. FY 2020
2021-03-30 Polish
GK Selvita_SSF_SSZ_XBRL_zip
Annual Report (ESEF) Classification · 100% confidence FY 2020
2021-03-30 Polish
Sprawozdanie biegłego rewidenta EY z badania SSF_2020.xhtml
Regulatory Filings Classification · 95% confidence The document text is extremely short ("Untitled - - - - - - - - ") and contains no substantive financial or regulatory information. Given the lack of content, it cannot be classified into any specific financial report type (10-K, ER, IR, etc.). According to Rule 3, the most appropriate fallback category for an unclassifiable or minimal document is 'Regulatory Filings' (RNS), as it represents a general regulatory announcement or placeholder.
2021-03-30 Italian
Sprawozdanie biegłego rewidenta EY z badania SSF_2020_html.xades
Regulatory Filings Classification · 95% confidence The document provided is not standard readable text but appears to be the raw XML content of a digitally signed document, likely an XAdES or similar XML Signature structure, given the presence of tags like <Signature>, <SignedInfo>, <SignatureValue>, <KeyInfo>, and <QualifyingProperties>. The document length is very large (5.6 million characters), suggesting it contains substantial embedded data, which is common for filings that include large attachments or complex structures. Crucially, the content itself is not a narrative report (like 10-K, ER, or IR) but a signature block. However, the embedded object data (Base64 encoded content) is present, which suggests this XML file is either the filing itself or a wrapper/attachment for the filing. Looking at the embedded data's structure (the base64 string starting with 'PGh0bWwgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGh0bWw+'), it decodes to HTML content, which often contains the main body of a filing or presentation. Given the complexity, the presence of digital signatures (often required for official regulatory submissions in certain jurisdictions, like Polish filings indicated by 'Polska Wytwórnia Papierów Wartościowych S.A.' in the certificate), and the large size, this is most likely a comprehensive regulatory submission. Since it is not explicitly an Annual Report (10-K) or an Interim Report (IR), and it is a complex, signed document, the most appropriate general category for a complex, official regulatory document that doesn't fit a specific financial report type is 'Regulatory Filings' (RNS), or potentially an Investor Presentation (IP) if the decoded HTML is a presentation. However, without seeing the decoded content, and recognizing this as a signed wrapper for a large document, 'RNS' (Regulatory Filings - general fallback for miscellaneous filings) is the safest classification for a complex, signed regulatory artifact that isn't a standard financial statement. Revisiting the definitions: If this were an Investor Presentation (IP), the text would usually contain slides/presentation language. If it were a Financial Supplement (XLSX), the text would be minimal announcing the attachment. Since this is a large, signed XML structure, it strongly implies a formal submission to a regulator. I will classify it as RNS as the best fit for a complex, signed regulatory artifact that isn't a standard financial report form.
2021-03-30 Polish
Sprawozdanie biegłego rewidenta EY z badania SSF_2020_pdf
Audit Report / Information Classification · 99% confidence The document text is explicitly titled "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA" (Independent Auditor's Report on the Audit) and details the audit opinion on the consolidated financial statements for the period ending December 31, 2020. It discusses compliance with International Standards on Auditing (KSB/MSR) and outlines Key Audit Matters (Kluczowe sprawy badania), such as revenue recognition under IFRS 15. This content is the core component of an Audit Report, fitting the definition for Code AR (Audit Report / Information). It is not a general Annual Report (10-K) as it is specifically the auditor's opinion, nor is it a mere announcement (RPA/RNS) because the full report content is present, despite the introductory note mentioning it's an XHTML conversion. FY 2020
2021-03-30 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.